Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov
The protocol below describes an in silico method for drug repositioning (drug repurposing). The data source is ClinicalTrials.gov , which contains about a quarter of a million clinical studies. Mining such rich and clean clinical summary data could be helpful to many health-related researches. Described here is a method that utilizes serious adverse event data to identify potential new uses of drugs and dietary supplements (repositioning).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1903 |
|---|---|
| Enthalten in: |
Methods in molecular biology (Clifton, N.J.) - 1903(2019) vom: 13., Seite 61-72 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Su, Eric Wen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adverse event |
|---|
| Anmerkungen: |
Date Completed 10.06.2019 Date Revised 13.06.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/978-1-4939-8955-3_4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM291773869 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM291773869 | ||
| 003 | DE-627 | ||
| 005 | 20231225071618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/978-1-4939-8955-3_4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0972.xml |
| 035 | |a (DE-627)NLM291773869 | ||
| 035 | |a (NLM)30547436 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Su, Eric Wen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.06.2019 | ||
| 500 | |a Date Revised 13.06.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The protocol below describes an in silico method for drug repositioning (drug repurposing). The data source is ClinicalTrials.gov , which contains about a quarter of a million clinical studies. Mining such rich and clean clinical summary data could be helpful to many health-related researches. Described here is a method that utilizes serious adverse event data to identify potential new uses of drugs and dietary supplements (repositioning) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Adverse event | |
| 650 | 4 | |a ClinicalTrials.gov | |
| 650 | 4 | |a Drug repositioning | |
| 650 | 4 | |a Drug repurposing | |
| 650 | 4 | |a I2E | |
| 650 | 4 | |a Indication discovery | |
| 650 | 4 | |a PolyAnalyst | |
| 650 | 4 | |a Text mining | |
| 773 | 0 | 8 | |i Enthalten in |t Methods in molecular biology (Clifton, N.J.) |d 1984 |g 1903(2019) vom: 13., Seite 61-72 |w (DE-627)NLM074849794 |x 1940-6029 |7 nnns |
| 773 | 1 | 8 | |g volume:1903 |g year:2019 |g day:13 |g pages:61-72 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/978-1-4939-8955-3_4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 1903 |j 2019 |b 13 |h 61-72 | ||